The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans

Published:2007-12-26 Issue:2 Volume:105 Page:663-667
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Berkenstam A.,Kristensen J.,Mellstrom K.,Carlsson B.,Malm J.,Rehnmark S.,Garg N.,Andersson C. M.,Rudling M.,Sjoberg F.,Angelin B.,Baxter J. D.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference26 articles.

1. Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins

2. Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy

3. Hypothyroidism and Atherosclerosis

4. A CONTROLLED STUDY OF THYROID ANALOGS IN THE THERAPY OF OBESITY

5. Effect of Levothyroxine Replacement on Lipid Profile and Intima-Media Thickness in Subclinical Hypothyroidism: A Double-Blind, Placebo- Controlled Study

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug discovery targeting thyroid hormone receptor β (THRβ) for the treatment of liver diseases and other medical indications;Acta Pharmaceutica Sinica B;2024-08

2. Potential therapeutic strategies for MASH: from preclinical to clinical development;Life Metabolism;2024-07-06

3. A new mechanism of thyroid hormone receptor β agonists ameliorating nonalcoholic steatohepatitis by inhibiting intestinal lipid absorption via remodeling bile acid profiles;Acta Pharmacologica Sinica;2024-05-24

4. Molecular Dynamic Simulation To Reveal the Mechanism Underlying MGL-3196 Resistance to Thyroxine Receptor Beta;ACS Omega;2024-05-01

5. Selective Agonists of Thyroid Hormone Receptor Beta: Promising Tools for the Treatment of Nonalcoholic Fatty Liver Disease;Endocrinology and Metabolism;2024-04-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3